Lipella Pharmaceuticals Inc. (LIPO) EBITDA Margin (2023 - 2025)
Lipella Pharmaceuticals' EBITDA Margin was -1563.36% in Q2 2025, down 865.96 percentage points from -697.40% a year earlier and down 537.70 percentage points from the prior quarter.
Powered by 
Analysis
Lipella Pharmaceuticals Inc. (LIPO) EBITDA Margin (2023 - 2025) Analysis & Trends
For FY2024, EBITDA Margin at Lipella Pharmaceuticals came in at -946.69%, up 108.49 percentage points from FY2023.
- In earlier years, EBITDA Margin was -1055.18% in FY2023 (+351.08 pp) and -1406.26% in FY2022.
- Quarterly EBITDA Margin has moved between -1814.75% (Q3 2024) and -603.16% (Q4 2023) over five years.
- Compared with a year earlier, EBITDA Margin has declined for three straight quarters.
- Per Business Quant data, LIPO's EBITDA Margin in the three quarters before Q2 2025 was -1025.66% (Q1 2025), -835.26% (Q4 2024) and -1814.75% (Q3 2024).
Peer Set
Peer Comparison
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | -1,563.36% |
| Mar 31, 2025 | -1,025.66% |
| Dec 31, 2024 | -835.26% |
| Sep 30, 2024 | -1,814.75% |
| Jun 30, 2024 | -697.40% |
| Mar 31, 2024 | -834.20% |
| Dec 31, 2023 | -603.16% |
API Access
Lipella Pharmaceuticals Inc. EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=LIPO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "LIPO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=LIPO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();